These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 21338625

  • 1. Within-host co-evolution of Gag P453L and protease D30N/N88D demonstrates virological advantage in a highly protease inhibitor-exposed HIV-1 case.
    Shibata J, Sugiura W, Ode H, Iwatani Y, Sato H, Tsang H, Matsuda M, Hasegawa N, Ren F, Tanaka H.
    Antiviral Res; 2011 Apr; 90(1):33-41. PubMed ID: 21338625
    [Abstract] [Full Text] [Related]

  • 2. Compensatory mutations at the HIV cleavage sites p7/p1 and p1/p6-gag in therapy-naive and therapy-experienced patients.
    Verheyen J, Litau E, Sing T, Däumer M, Balduin M, Oette M, Fätkenheuer G, Rockstroh JK, Schuldenzucker U, Hoffmann D, Pfister H, Kaiser R.
    Antivir Ther; 2006 Apr; 11(7):879-87. PubMed ID: 17302250
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. HIV-1 protease-substrate coevolution in nelfinavir resistance.
    Kolli M, Ozen A, Kurt-Yilmaz N, Schiffer CA.
    J Virol; 2014 Jul; 88(13):7145-54. PubMed ID: 24719428
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Co-evolution of nelfinavir-resistant HIV-1 protease and the p1-p6 substrate.
    Kolli M, Lastere S, Schiffer CA.
    Virology; 2006 Apr 10; 347(2):405-9. PubMed ID: 16430939
    [Abstract] [Full Text] [Related]

  • 14. Association of Gag cleavage sites to protease mutations and to virological response in HIV-1 treated patients.
    Malet I, Roquebert B, Dalban C, Wirden M, Amellal B, Agher R, Simon A, Katlama C, Costagliola D, Calvez V, Marcelin AG.
    J Infect; 2007 Apr 10; 54(4):367-74. PubMed ID: 16875739
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Impact of gag mutations on selection of darunavir resistance mutations in HIV-1 protease.
    Lambert-Niclot S, Flandre P, Malet I, Canestri A, Soulié C, Tubiana R, Brunet C, Wirden M, Katlama C, Calvez V, Marcelin AG.
    J Antimicrob Chemother; 2008 Nov 10; 62(5):905-8. PubMed ID: 18765410
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.